IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$75.81 USD
-1.80 (-2.32%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $75.85 +0.04 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This reflects a positive earnings surprise of 11.11%. Look out for ITCI's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 32%.
Earnings History
Price & Consensus
Zacks News for ITCI
Intra-Cellular (ITCI) Q2 Loss Narrower Than Expected, Sales Beat
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services